Jae Won Chang

This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Scripps Research Institute, Dana-Farber-Cancer Institute Inc., Abide Therapeutics, Inc.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Won Chang. Retrieved from https://idiyas.com/inventor/jae-won-chang-to0x91ho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 3)

% Patents Active = 87.5

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 6.2

ph-index = 8

Forward Citations = 231(Granted Patents)

Location History:

Boston, MA (US) (2013 - 2014)
La Jolla, CA (US) (2016)
San Diego, CA (US) (2014 - 2024)

Company Filing History:

12 out of 1,208

Scripps Research Institute

patents

8 out of 1,268

Dana-Farber-Cancer Institute Inc.

patents

4 out of 18

Abide Therapeutics, Inc.

Whitehead Institute for Biomedical Research

patents

6. 1 out of 12

Lundbeck La Jolla Research Center, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

Areas of Expertise:

Carbamate Compounds

Myristate Inhibitors

Bcr-Abl

Anti-Cancer

Serine Hydrolase

Fused 2-Aminothiazole

mTOR Complexes

Modulators

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12018004 - Carbamate compounds and methods of making and using same (2024-06-25),

2. 11932646 - Small molecule myristate inhibitors of Bcr-abl and methods of use (2024-03-19),

3. 11530189 - Carbamate compounds and methods of making and using same (2022-12-20),

4. 11254682 - Small molecule myristate inhibitors of Bcr-abl and methods of use (2022-02-22),

5. 11021453 - Carbamate compounds and methods of making and using same (2021-06-01),

6. 10787455 - Small molecule myristate inhibitors of BCR-ABL and methods of use (2020-09-29),

7. 9957242 - Carbamate compounds and methods of making and using same (2018-05-01),

8. 9567302 - Carbamate compounds and of making and using same (2017-02-14),

9. 9505784 - Fused 2-aminothiazole compounds (2016-11-29),

10. 9487495 - Carbamate compounds and of making and using same (2016-11-08),

11. 9249128 - Anti-cancer serine hydrolase inhibitory carbamates (2016-02-02),

12. 9133148 - Carbamate compounds and of making and using same (2015-09-15),

13. 8921336 - Small molecule myristate inhibitors of BCR-ABL and methods of use (2014-12-30),

14. 8889706 - Soluble mTOR complexes and modulators thereof (2014-11-18),

15. 8765747 - Fused 2-aminothiazole compounds (2014-07-01),

Title: Unveiling the Innovations of Inventor Jae Won Chang

Introduction:

In the realm of inventions and breakthroughs, inventor Jae Won Chang emerges as a prominent figure, hailing from the vibrant city of San Diego, California. With a remarkable portfolio boasting 15 patents, Chang has been at the forefront of pioneering advancements in the field of medicinal chemistry and pharmaceuticals.

Latest Patents:

Chang's latest patents showcase his expertise and ingenuity. One of his recent creations includes "Small molecule myristate inhibitors of Bcr-abl," offering a novel approach for combating various types of cancers. Additionally, his patent on "Carbamate compounds as modulators of MAGL and/or ABHD6" presents innovative methods for treating patients with post-traumatic stress disorder.

Career Highlights:

Having made significant contributions to the scientific community, Jae Won Chang has been associated with esteemed institutions such as The Scripps Research Institute and Dana-Farber Cancer Institute. His dedication to research and development has not only led to groundbreaking inventions but has also paved the way for transformative discoveries in the pharmaceutical industry.

Collaborations:

Throughout his career, Chang has collaborated with industry experts and visionaries, including notable peers such as Nathanael Schiander Gray and Jianming Zhang. These collaborations have not only enriched his projects but have also fostered a culture of innovation and knowledge-sharing within the scientific community.

Conclusion:

Inventor Jae Won Chang's unwavering commitment to innovation and scientific advancement has solidified his position as a trailblazer in the field of medicinal chemistry. His relentless pursuit of excellence and groundbreaking inventions continue to shape the landscape of modern medicine, offering hope and transformative solutions to individuals in need.

Profile summary based on public USPTO records.